nodes	percent_of_prediction	percent_of_DWPC	metapath
Rifaximin—NR1I2—obesity	0.587	1	CbGaD
Rifaximin—CYP3A4—Sibutramine—obesity	0.0543	0.27	CbGbCtD
Rifaximin—CYP3A4—Benzphetamine—obesity	0.0411	0.204	CbGbCtD
Rifaximin—CYP3A4—Bupropion—obesity	0.035	0.174	CbGbCtD
Rifaximin—CYP3A4—Orlistat—obesity	0.0285	0.142	CbGbCtD
Rifaximin—CYP3A4—Cimetidine—obesity	0.0257	0.127	CbGbCtD
Rifaximin—CYP3A4—Topiramate—obesity	0.0168	0.0834	CbGbCtD
Rifaximin—NR1I2—Drug Induction of Bile Acid Pathway—NR1I3—obesity	0.00328	0.0731	CbGpPWpGaD
Rifaximin—NR1I2—Drug Induction of Bile Acid Pathway—SULT2A1—obesity	0.00249	0.0554	CbGpPWpGaD
Rifaximin—NR1I2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARD—obesity	0.00207	0.0461	CbGpPWpGaD
Rifaximin—NR1I2—Nuclear Receptors—PPARD—obesity	0.00189	0.0422	CbGpPWpGaD
Rifaximin—NR1I2—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I3—obesity	0.00188	0.042	CbGpPWpGaD
Rifaximin—NR1I2—Nuclear Receptors—NR1I3—obesity	0.00172	0.0384	CbGpPWpGaD
Rifaximin—NR1I2—Nuclear Receptor transcription pathway—PPARD—obesity	0.0015	0.0333	CbGpPWpGaD
Rifaximin—Rifampicin—NR1I2—obesity	0.00147	0.761	CrCbGaD
Rifaximin—NR1I2—Nuclear Receptor transcription pathway—NR1I3—obesity	0.00136	0.0304	CbGpPWpGaD
Rifaximin—NR1I2—Nuclear Receptor transcription pathway—NR0B2—obesity	0.00136	0.0304	CbGpPWpGaD
Rifaximin—CYP3A4—Irinotecan Pathway—NPC1—obesity	0.0012	0.0267	CbGpPWpGaD
Rifaximin—CYP3A4—Felbamate Metabolism—CYP2E1—obesity	0.00116	0.026	CbGpPWpGaD
Rifaximin—NR1I2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—obesity	0.00104	0.0233	CbGpPWpGaD
Rifaximin—NR1I2—Nuclear Receptors—ESR2—obesity	0.000937	0.0209	CbGpPWpGaD
Rifaximin—CYP3A4—Irinotecan Pathway—CES1—obesity	0.00083	0.0185	CbGpPWpGaD
Rifaximin—NR1I2—Nuclear Receptors—AR—obesity	0.000828	0.0185	CbGpPWpGaD
Rifaximin—NR1I2—Nuclear Receptor transcription pathway—ESR2—obesity	0.000741	0.0165	CbGpPWpGaD
Rifaximin—CYP3A4—Liver X Receptor Pathway—SCD—obesity	0.0007	0.0156	CbGpPWpGaD
Rifaximin—NR1I2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—obesity	0.000686	0.0153	CbGpPWpGaD
Rifaximin—NR1I2—Nuclear Receptors—NR3C1—obesity	0.00067	0.0149	CbGpPWpGaD
Rifaximin—NR1I2—Nuclear Receptor transcription pathway—AR—obesity	0.000654	0.0146	CbGpPWpGaD
Rifaximin—NR1I2—Nuclear Receptors—PPARA—obesity	0.000627	0.014	CbGpPWpGaD
Rifaximin—NR1I2—Nuclear Receptors—ESR1—obesity	0.000568	0.0127	CbGpPWpGaD
Rifaximin—NR1I2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—obesity	0.000567	0.0126	CbGpPWpGaD
Rifaximin—NR1I2—Nuclear Receptor transcription pathway—NR3C1—obesity	0.000529	0.0118	CbGpPWpGaD
Rifaximin—NR1I2—Nuclear Receptors—PPARG—obesity	0.000519	0.0116	CbGpPWpGaD
Rifaximin—NR1I2—Nuclear Receptor transcription pathway—PPARA—obesity	0.000496	0.0111	CbGpPWpGaD
Rifaximin—Rifampicin—CYP2E1—obesity	0.000462	0.239	CrCbGaD
Rifaximin—NR1I2—Nuclear Receptor transcription pathway—ESR1—obesity	0.000449	0.01	CbGpPWpGaD
Rifaximin—NR1I2—Nuclear Receptor transcription pathway—PPARG—obesity	0.00041	0.00914	CbGpPWpGaD
Rifaximin—CYP3A4—Estrogen metabolism—STS—obesity	0.000407	0.00907	CbGpPWpGaD
Rifaximin—CYP3A4—Benzo(a)pyrene metabolism—AKR1C3—obesity	0.0004	0.00892	CbGpPWpGaD
Rifaximin—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—obesity	0.000392	0.00874	CbGpPWpGaD
Rifaximin—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I3—obesity	0.000379	0.00846	CbGpPWpGaD
Rifaximin—CYP3A4—Liver X Receptor Pathway—SREBF1—obesity	0.000351	0.00784	CbGpPWpGaD
Rifaximin—CYP3A4—Farnesoid X Receptor  Pathway—NR0B2—obesity	0.000347	0.00774	CbGpPWpGaD
Rifaximin—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—obesity	0.000347	0.00774	CbGpPWpGaD
Rifaximin—CYP3A4—Liver X Receptor Pathway—FASN—obesity	0.000334	0.00746	CbGpPWpGaD
Rifaximin—CYP3A4—Drug Induction of Bile Acid Pathway—SULT2A1—obesity	0.000287	0.00641	CbGpPWpGaD
Rifaximin—CYP3A4—Farnesoid X Receptor  Pathway—SULT2A1—obesity	0.000263	0.00586	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—APOBEC1—obesity	0.00026	0.0058	CbGpPWpGaD
Rifaximin—NR1I2—Generic Transcription Pathway—PPARD—obesity	0.000258	0.00576	CbGpPWpGaD
Rifaximin—CYP3A4—Irinotecan Pathway—BCHE—obesity	0.000254	0.00567	CbGpPWpGaD
Rifaximin—CYP3A4—Tamoxifen metabolism—SULT2A1—obesity	0.000243	0.00541	CbGpPWpGaD
Rifaximin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARD—obesity	0.000239	0.00533	CbGpPWpGaD
Rifaximin—NR1I2—Generic Transcription Pathway—NR1I3—obesity	0.000235	0.00525	CbGpPWpGaD
Rifaximin—NR1I2—Generic Transcription Pathway—NR0B2—obesity	0.000235	0.00525	CbGpPWpGaD
Rifaximin—CYP3A4—Constitutive Androstane Receptor Pathway—NR1I3—obesity	0.000229	0.0051	CbGpPWpGaD
Rifaximin—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—obesity	0.000221	0.00492	CbGpPWpGaD
Rifaximin—Dermatitis—Diethylpropion—obesity	0.000219	0.00133	CcSEcCtD
Rifaximin—Dizziness—Cimetidine—obesity	0.000218	0.00133	CcSEcCtD
Rifaximin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I3—obesity	0.000218	0.00486	CbGpPWpGaD
Rifaximin—Haemoglobin—Bupropion—obesity	0.000217	0.00132	CcSEcCtD
Rifaximin—Headache—Diethylpropion—obesity	0.000217	0.00132	CcSEcCtD
Rifaximin—Rhinitis—Bupropion—obesity	0.000217	0.00132	CcSEcCtD
Rifaximin—Haemorrhage—Bupropion—obesity	0.000216	0.00131	CcSEcCtD
Rifaximin—Malnutrition—Sibutramine—obesity	0.000216	0.00131	CcSEcCtD
Rifaximin—Back pain—Orlistat—obesity	0.000216	0.00131	CcSEcCtD
Rifaximin—Hypoaesthesia—Bupropion—obesity	0.000215	0.00131	CcSEcCtD
Rifaximin—Pharyngitis—Bupropion—obesity	0.000215	0.0013	CcSEcCtD
Rifaximin—Muscle spasms—Orlistat—obesity	0.000215	0.0013	CcSEcCtD
Rifaximin—Urinary tract disorder—Bupropion—obesity	0.000214	0.0013	CcSEcCtD
Rifaximin—Oedema peripheral—Bupropion—obesity	0.000213	0.0013	CcSEcCtD
Rifaximin—Hot flush—Topiramate—obesity	0.000213	0.00129	CcSEcCtD
Rifaximin—Flatulence—Sibutramine—obesity	0.000213	0.00129	CcSEcCtD
Rifaximin—Urethral disorder—Bupropion—obesity	0.000212	0.00129	CcSEcCtD
Rifaximin—Amnesia—Topiramate—obesity	0.000212	0.00129	CcSEcCtD
Rifaximin—Menopausal symptoms—Topiramate—obesity	0.000211	0.00128	CcSEcCtD
Rifaximin—Vomiting—Cimetidine—obesity	0.00021	0.00128	CcSEcCtD
Rifaximin—Back pain—Sibutramine—obesity	0.000209	0.00127	CcSEcCtD
Rifaximin—Rash—Cimetidine—obesity	0.000208	0.00126	CcSEcCtD
Rifaximin—Dermatitis—Cimetidine—obesity	0.000208	0.00126	CcSEcCtD
Rifaximin—Muscle spasms—Sibutramine—obesity	0.000208	0.00126	CcSEcCtD
Rifaximin—Ill-defined disorder—Orlistat—obesity	0.000207	0.00126	CcSEcCtD
Rifaximin—Headache—Cimetidine—obesity	0.000207	0.00126	CcSEcCtD
Rifaximin—Nausea—Diethylpropion—obesity	0.000206	0.00125	CcSEcCtD
Rifaximin—Hypoglycaemia—Topiramate—obesity	0.000204	0.00124	CcSEcCtD
Rifaximin—Angioedema—Orlistat—obesity	0.000204	0.00124	CcSEcCtD
Rifaximin—Tremor—Sibutramine—obesity	0.000202	0.00123	CcSEcCtD
Rifaximin—Tinnitus—Bupropion—obesity	0.000202	0.00123	CcSEcCtD
Rifaximin—Malaise—Orlistat—obesity	0.000201	0.00122	CcSEcCtD
Rifaximin—Flushing—Bupropion—obesity	0.000201	0.00122	CcSEcCtD
Rifaximin—Vertigo—Orlistat—obesity	0.000201	0.00122	CcSEcCtD
Rifaximin—Ill-defined disorder—Sibutramine—obesity	0.0002	0.00122	CcSEcCtD
Rifaximin—Hyponatraemia—Topiramate—obesity	0.0002	0.00122	CcSEcCtD
Rifaximin—Anaemia—Sibutramine—obesity	0.0002	0.00121	CcSEcCtD
Rifaximin—Pain in extremity—Topiramate—obesity	0.000199	0.00121	CcSEcCtD
Rifaximin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—obesity	0.000199	0.00444	CbGpPWpGaD
Rifaximin—CYP3A4—Estrogen metabolism—NQO1—obesity	0.000199	0.00443	CbGpPWpGaD
Rifaximin—Angioedema—Sibutramine—obesity	0.000197	0.0012	CcSEcCtD
Rifaximin—NR1I2—Gene Expression—CTNNBL1—obesity	0.000197	0.0044	CbGpPWpGaD
Rifaximin—Angiopathy—Bupropion—obesity	0.000196	0.00119	CcSEcCtD
Rifaximin—Migraine—Topiramate—obesity	0.000196	0.00119	CcSEcCtD
Rifaximin—Nausea—Cimetidine—obesity	0.000196	0.00119	CcSEcCtD
Rifaximin—Mediastinal disorder—Bupropion—obesity	0.000195	0.00118	CcSEcCtD
Rifaximin—Malaise—Sibutramine—obesity	0.000195	0.00118	CcSEcCtD
Rifaximin—Cough—Orlistat—obesity	0.000195	0.00118	CcSEcCtD
Rifaximin—Vertigo—Sibutramine—obesity	0.000194	0.00118	CcSEcCtD
Rifaximin—Syncope—Sibutramine—obesity	0.000194	0.00118	CcSEcCtD
Rifaximin—CYP3A4—Oxidation by Cytochrome P450—CYB5A—obesity	0.000194	0.00432	CbGpPWpGaD
Rifaximin—Myalgia—Orlistat—obesity	0.00019	0.00115	CcSEcCtD
Rifaximin—Chest pain—Orlistat—obesity	0.00019	0.00115	CcSEcCtD
Rifaximin—Loss of consciousness—Sibutramine—obesity	0.00019	0.00115	CcSEcCtD
Rifaximin—Mental disorder—Bupropion—obesity	0.00019	0.00115	CcSEcCtD
Rifaximin—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.000189	0.00115	CcSEcCtD
Rifaximin—Cough—Sibutramine—obesity	0.000189	0.00115	CcSEcCtD
Rifaximin—Malnutrition—Bupropion—obesity	0.000188	0.00114	CcSEcCtD
Rifaximin—Discomfort—Orlistat—obesity	0.000188	0.00114	CcSEcCtD
Rifaximin—Dry mouth—Orlistat—obesity	0.000186	0.00113	CcSEcCtD
Rifaximin—Flatulence—Bupropion—obesity	0.000186	0.00113	CcSEcCtD
Rifaximin—Dehydration—Topiramate—obesity	0.000185	0.00113	CcSEcCtD
Rifaximin—CYP3A4—Xenobiotics—CYP2E1—obesity	0.000185	0.00412	CbGpPWpGaD
Rifaximin—Myalgia—Sibutramine—obesity	0.000184	0.00112	CcSEcCtD
Rifaximin—Chest pain—Sibutramine—obesity	0.000184	0.00112	CcSEcCtD
Rifaximin—Arthralgia—Sibutramine—obesity	0.000184	0.00112	CcSEcCtD
Rifaximin—Anaphylactic shock—Orlistat—obesity	0.000182	0.00111	CcSEcCtD
Rifaximin—Back pain—Bupropion—obesity	0.000182	0.00111	CcSEcCtD
Rifaximin—Abdominal pain upper—Topiramate—obesity	0.000182	0.00111	CcSEcCtD
Rifaximin—Discomfort—Sibutramine—obesity	0.000182	0.0011	CcSEcCtD
Rifaximin—Muscle spasms—Bupropion—obesity	0.000181	0.0011	CcSEcCtD
Rifaximin—Infection—Orlistat—obesity	0.000181	0.0011	CcSEcCtD
Rifaximin—Dry mouth—Sibutramine—obesity	0.00018	0.00109	CcSEcCtD
Rifaximin—Aspartate aminotransferase increased—Topiramate—obesity	0.000179	0.00109	CcSEcCtD
Rifaximin—Nervous system disorder—Orlistat—obesity	0.000179	0.00109	CcSEcCtD
Rifaximin—Nasopharyngitis—Topiramate—obesity	0.000178	0.00108	CcSEcCtD
Rifaximin—Confusional state—Sibutramine—obesity	0.000178	0.00108	CcSEcCtD
Rifaximin—CYP3A4—Tamoxifen metabolism—CYP2E1—obesity	0.000177	0.00396	CbGpPWpGaD
Rifaximin—Skin disorder—Orlistat—obesity	0.000177	0.00108	CcSEcCtD
Rifaximin—CYP3A4—Aflatoxin activation and detoxification—GGT1—obesity	0.000177	0.00394	CbGpPWpGaD
Rifaximin—Tremor—Bupropion—obesity	0.000176	0.00107	CcSEcCtD
Rifaximin—Anaphylactic shock—Sibutramine—obesity	0.000176	0.00107	CcSEcCtD
Rifaximin—Hyperhidrosis—Orlistat—obesity	0.000176	0.00107	CcSEcCtD
Rifaximin—Infection—Sibutramine—obesity	0.000175	0.00106	CcSEcCtD
Rifaximin—Ill-defined disorder—Bupropion—obesity	0.000175	0.00106	CcSEcCtD
Rifaximin—Anaemia—Bupropion—obesity	0.000174	0.00106	CcSEcCtD
Rifaximin—Shock—Sibutramine—obesity	0.000174	0.00105	CcSEcCtD
Rifaximin—Abdominal distension—Topiramate—obesity	0.000173	0.00105	CcSEcCtD
Rifaximin—CYP3A4—Constitutive Androstane Receptor Pathway—SULT2A1—obesity	0.000173	0.00386	CbGpPWpGaD
Rifaximin—Dysphagia—Topiramate—obesity	0.000172	0.00105	CcSEcCtD
Rifaximin—Angioedema—Bupropion—obesity	0.000172	0.00105	CcSEcCtD
Rifaximin—Skin disorder—Sibutramine—obesity	0.000171	0.00104	CcSEcCtD
Rifaximin—CYP3A4—Tryptophan metabolism—ECHS1—obesity	0.000171	0.00381	CbGpPWpGaD
Rifaximin—Hyperhidrosis—Sibutramine—obesity	0.00017	0.00104	CcSEcCtD
Rifaximin—Malaise—Bupropion—obesity	0.00017	0.00103	CcSEcCtD
Rifaximin—Vertigo—Bupropion—obesity	0.000169	0.00103	CcSEcCtD
Rifaximin—Syncope—Bupropion—obesity	0.000169	0.00103	CcSEcCtD
Rifaximin—Anorexia—Sibutramine—obesity	0.000168	0.00102	CcSEcCtD
Rifaximin—Sweating increased—Topiramate—obesity	0.000168	0.00102	CcSEcCtD
Rifaximin—CYP3A4—Estrogen metabolism—COMT—obesity	0.000166	0.00371	CbGpPWpGaD
Rifaximin—Musculoskeletal discomfort—Orlistat—obesity	0.000166	0.00101	CcSEcCtD
Rifaximin—Loss of consciousness—Bupropion—obesity	0.000166	0.00101	CcSEcCtD
Rifaximin—Abdominal discomfort—Topiramate—obesity	0.000165	0.001	CcSEcCtD
Rifaximin—Insomnia—Orlistat—obesity	0.000165	0.001	CcSEcCtD
Rifaximin—Hypotension—Sibutramine—obesity	0.000165	0.001	CcSEcCtD
Rifaximin—Cough—Bupropion—obesity	0.000164	0.000999	CcSEcCtD
Rifaximin—Dysuria—Topiramate—obesity	0.000161	0.000979	CcSEcCtD
Rifaximin—Neutropenia—Topiramate—obesity	0.000161	0.000979	CcSEcCtD
Rifaximin—CYP3A4—Tryptophan metabolism—HADH—obesity	0.000161	0.00359	CbGpPWpGaD
Rifaximin—Musculoskeletal discomfort—Sibutramine—obesity	0.000161	0.000976	CcSEcCtD
Rifaximin—Chest pain—Bupropion—obesity	0.00016	0.000974	CcSEcCtD
Rifaximin—Myalgia—Bupropion—obesity	0.00016	0.000974	CcSEcCtD
Rifaximin—Arthralgia—Bupropion—obesity	0.00016	0.000974	CcSEcCtD
Rifaximin—Upper respiratory tract infection—Topiramate—obesity	0.00016	0.000973	CcSEcCtD
Rifaximin—Insomnia—Sibutramine—obesity	0.00016	0.000969	CcSEcCtD
Rifaximin—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.000159	0.000968	CcSEcCtD
Rifaximin—Pollakiuria—Topiramate—obesity	0.000159	0.000967	CcSEcCtD
Rifaximin—Discomfort—Bupropion—obesity	0.000158	0.000963	CcSEcCtD
Rifaximin—Decreased appetite—Orlistat—obesity	0.000158	0.000962	CcSEcCtD
Rifaximin—Gastrointestinal disorder—Orlistat—obesity	0.000157	0.000956	CcSEcCtD
Rifaximin—Dyspnoea—Sibutramine—obesity	0.000157	0.000955	CcSEcCtD
Rifaximin—Photosensitivity reaction—Topiramate—obesity	0.000157	0.000955	CcSEcCtD
Rifaximin—CYP3A4—Farnesoid X Receptor  Pathway—PPARGC1A—obesity	0.000157	0.0035	CbGpPWpGaD
Rifaximin—Fatigue—Orlistat—obesity	0.000157	0.000955	CcSEcCtD
Rifaximin—Dry mouth—Bupropion—obesity	0.000157	0.000953	CcSEcCtD
Rifaximin—Weight increased—Topiramate—obesity	0.000157	0.000952	CcSEcCtD
Rifaximin—Weight decreased—Topiramate—obesity	0.000156	0.000947	CcSEcCtD
Rifaximin—Pain—Orlistat—obesity	0.000156	0.000947	CcSEcCtD
Rifaximin—Hyperglycaemia—Topiramate—obesity	0.000155	0.000944	CcSEcCtD
Rifaximin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26B1—obesity	0.000155	0.00346	CbGpPWpGaD
Rifaximin—Confusional state—Bupropion—obesity	0.000155	0.000942	CcSEcCtD
Rifaximin—Pneumonia—Topiramate—obesity	0.000154	0.000939	CcSEcCtD
Rifaximin—Anaphylactic shock—Bupropion—obesity	0.000154	0.000934	CcSEcCtD
Rifaximin—Infestation NOS—Topiramate—obesity	0.000154	0.000933	CcSEcCtD
Rifaximin—Infestation—Topiramate—obesity	0.000154	0.000933	CcSEcCtD
Rifaximin—Decreased appetite—Sibutramine—obesity	0.000153	0.000931	CcSEcCtD
Rifaximin—Depression—Topiramate—obesity	0.000153	0.00093	CcSEcCtD
Rifaximin—CYP3A4—Oxidation by Cytochrome P450—CYP26B1—obesity	0.000153	0.00341	CbGpPWpGaD
Rifaximin—Infection—Bupropion—obesity	0.000153	0.000928	CcSEcCtD
Rifaximin—Gastrointestinal disorder—Sibutramine—obesity	0.000152	0.000925	CcSEcCtD
Rifaximin—Shock—Bupropion—obesity	0.000151	0.000919	CcSEcCtD
Rifaximin—Pain—Sibutramine—obesity	0.000151	0.000916	CcSEcCtD
Rifaximin—Constipation—Sibutramine—obesity	0.000151	0.000916	CcSEcCtD
Rifaximin—Nervous system disorder—Bupropion—obesity	0.000151	0.000916	CcSEcCtD
Rifaximin—Feeling abnormal—Orlistat—obesity	0.00015	0.000912	CcSEcCtD
Rifaximin—Skin disorder—Bupropion—obesity	0.000149	0.000907	CcSEcCtD
Rifaximin—Gastrointestinal pain—Orlistat—obesity	0.000149	0.000905	CcSEcCtD
Rifaximin—Hyperhidrosis—Bupropion—obesity	0.000149	0.000903	CcSEcCtD
Rifaximin—Anorexia—Bupropion—obesity	0.000147	0.00089	CcSEcCtD
Rifaximin—Haematuria—Topiramate—obesity	0.000146	0.00089	CcSEcCtD
Rifaximin—Feeling abnormal—Sibutramine—obesity	0.000145	0.000883	CcSEcCtD
Rifaximin—Epistaxis—Topiramate—obesity	0.000145	0.00088	CcSEcCtD
Rifaximin—Urticaria—Orlistat—obesity	0.000145	0.00088	CcSEcCtD
Rifaximin—Gastrointestinal pain—Sibutramine—obesity	0.000144	0.000876	CcSEcCtD
Rifaximin—Body temperature increased—Orlistat—obesity	0.000144	0.000875	CcSEcCtD
Rifaximin—Abdominal pain—Orlistat—obesity	0.000144	0.000875	CcSEcCtD
Rifaximin—Hypotension—Bupropion—obesity	0.000144	0.000873	CcSEcCtD
Rifaximin—Urticaria—Sibutramine—obesity	0.00014	0.000851	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Bupropion—obesity	0.00014	0.000851	CcSEcCtD
Rifaximin—Abdominal pain—Sibutramine—obesity	0.000139	0.000847	CcSEcCtD
Rifaximin—Body temperature increased—Sibutramine—obesity	0.000139	0.000847	CcSEcCtD
Rifaximin—Insomnia—Bupropion—obesity	0.000139	0.000845	CcSEcCtD
Rifaximin—Haemoglobin—Topiramate—obesity	0.000139	0.000842	CcSEcCtD
Rifaximin—Rhinitis—Topiramate—obesity	0.000138	0.00084	CcSEcCtD
Rifaximin—Haemorrhage—Topiramate—obesity	0.000138	0.000838	CcSEcCtD
Rifaximin—Hypoaesthesia—Topiramate—obesity	0.000137	0.000833	CcSEcCtD
Rifaximin—Dyspnoea—Bupropion—obesity	0.000137	0.000833	CcSEcCtD
Rifaximin—Pharyngitis—Topiramate—obesity	0.000137	0.000831	CcSEcCtD
Rifaximin—Urinary tract disorder—Topiramate—obesity	0.000136	0.000827	CcSEcCtD
Rifaximin—Oedema peripheral—Topiramate—obesity	0.000136	0.000825	CcSEcCtD
Rifaximin—Urethral disorder—Topiramate—obesity	0.000135	0.000821	CcSEcCtD
Rifaximin—NR1I2—Generic Transcription Pathway—PARP1—obesity	0.000135	0.00301	CbGpPWpGaD
Rifaximin—Hypersensitivity—Orlistat—obesity	0.000134	0.000816	CcSEcCtD
Rifaximin—Decreased appetite—Bupropion—obesity	0.000134	0.000812	CcSEcCtD
Rifaximin—Gastrointestinal disorder—Bupropion—obesity	0.000133	0.000806	CcSEcCtD
Rifaximin—Fatigue—Bupropion—obesity	0.000133	0.000805	CcSEcCtD
Rifaximin—Constipation—Bupropion—obesity	0.000131	0.000799	CcSEcCtD
Rifaximin—Pain—Bupropion—obesity	0.000131	0.000799	CcSEcCtD
Rifaximin—Asthenia—Orlistat—obesity	0.000131	0.000794	CcSEcCtD
Rifaximin—Hypersensitivity—Sibutramine—obesity	0.00013	0.000789	CcSEcCtD
Rifaximin—Pruritus—Orlistat—obesity	0.000129	0.000783	CcSEcCtD
Rifaximin—Tinnitus—Topiramate—obesity	0.000129	0.000781	CcSEcCtD
Rifaximin—Flushing—Topiramate—obesity	0.000128	0.000777	CcSEcCtD
Rifaximin—NR1I2—Generic Transcription Pathway—ESR2—obesity	0.000128	0.00285	CbGpPWpGaD
Rifaximin—Feeling abnormal—Bupropion—obesity	0.000127	0.00077	CcSEcCtD
Rifaximin—Asthenia—Sibutramine—obesity	0.000127	0.000769	CcSEcCtD
Rifaximin—CYP3A4—Phase 1 - Functionalization of compounds—CYP26B1—obesity	0.000126	0.00281	CbGpPWpGaD
Rifaximin—Gastrointestinal pain—Bupropion—obesity	0.000126	0.000764	CcSEcCtD
Rifaximin—Angiopathy—Topiramate—obesity	0.000125	0.00076	CcSEcCtD
Rifaximin—Pruritus—Sibutramine—obesity	0.000125	0.000758	CcSEcCtD
Rifaximin—Diarrhoea—Orlistat—obesity	0.000125	0.000758	CcSEcCtD
Rifaximin—NR1I2—Gene Expression—PPARD—obesity	0.000124	0.00277	CbGpPWpGaD
Rifaximin—Mediastinal disorder—Topiramate—obesity	0.000124	0.000755	CcSEcCtD
Rifaximin—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—obesity	0.000123	0.00273	CbGpPWpGaD
Rifaximin—Urticaria—Bupropion—obesity	0.000122	0.000742	CcSEcCtD
Rifaximin—Body temperature increased—Bupropion—obesity	0.000122	0.000738	CcSEcCtD
Rifaximin—Abdominal pain—Bupropion—obesity	0.000122	0.000738	CcSEcCtD
Rifaximin—Mental disorder—Topiramate—obesity	0.000121	0.000734	CcSEcCtD
Rifaximin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—obesity	0.000121	0.00269	CbGpPWpGaD
Rifaximin—Diarrhoea—Sibutramine—obesity	0.000121	0.000733	CcSEcCtD
Rifaximin—Dizziness—Orlistat—obesity	0.00012	0.000732	CcSEcCtD
Rifaximin—Malnutrition—Topiramate—obesity	0.00012	0.000729	CcSEcCtD
Rifaximin—Flatulence—Topiramate—obesity	0.000118	0.000719	CcSEcCtD
Rifaximin—NR1I2—Generic Transcription Pathway—NCOA1—obesity	0.000118	0.00263	CbGpPWpGaD
Rifaximin—Dizziness—Sibutramine—obesity	0.000117	0.000709	CcSEcCtD
Rifaximin—Back pain—Topiramate—obesity	0.000116	0.000705	CcSEcCtD
Rifaximin—Vomiting—Orlistat—obesity	0.000116	0.000704	CcSEcCtD
Rifaximin—Muscle spasms—Topiramate—obesity	0.000115	0.000701	CcSEcCtD
Rifaximin—Rash—Orlistat—obesity	0.000115	0.000698	CcSEcCtD
Rifaximin—Dermatitis—Orlistat—obesity	0.000115	0.000697	CcSEcCtD
Rifaximin—CYP3A4—Constitutive Androstane Receptor Pathway—NCOA1—obesity	0.000115	0.00256	CbGpPWpGaD
Rifaximin—Headache—Orlistat—obesity	0.000114	0.000694	CcSEcCtD
Rifaximin—Hypersensitivity—Bupropion—obesity	0.000113	0.000688	CcSEcCtD
Rifaximin—NR1I2—Gene Expression—NR1I3—obesity	0.000113	0.00253	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—NR0B2—obesity	0.000113	0.00253	CbGpPWpGaD
Rifaximin—NR1I2—Generic Transcription Pathway—AR—obesity	0.000113	0.00252	CbGpPWpGaD
Rifaximin—Tremor—Topiramate—obesity	0.000112	0.000683	CcSEcCtD
Rifaximin—Vomiting—Sibutramine—obesity	0.000112	0.000681	CcSEcCtD
Rifaximin—Ill-defined disorder—Topiramate—obesity	0.000111	0.000677	CcSEcCtD
Rifaximin—Rash—Sibutramine—obesity	0.000111	0.000676	CcSEcCtD
Rifaximin—Dermatitis—Sibutramine—obesity	0.000111	0.000675	CcSEcCtD
Rifaximin—Anaemia—Topiramate—obesity	0.000111	0.000674	CcSEcCtD
Rifaximin—Headache—Sibutramine—obesity	0.00011	0.000671	CcSEcCtD
Rifaximin—Asthenia—Bupropion—obesity	0.00011	0.00067	CcSEcCtD
Rifaximin—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—obesity	0.00011	0.00246	CbGpPWpGaD
Rifaximin—Pruritus—Bupropion—obesity	0.000109	0.000661	CcSEcCtD
Rifaximin—Nausea—Orlistat—obesity	0.000108	0.000658	CcSEcCtD
Rifaximin—Malaise—Topiramate—obesity	0.000108	0.000658	CcSEcCtD
Rifaximin—Vertigo—Topiramate—obesity	0.000108	0.000655	CcSEcCtD
Rifaximin—Syncope—Topiramate—obesity	0.000108	0.000654	CcSEcCtD
Rifaximin—Loss of consciousness—Topiramate—obesity	0.000105	0.000641	CcSEcCtD
Rifaximin—Diarrhoea—Bupropion—obesity	0.000105	0.000639	CcSEcCtD
Rifaximin—Nausea—Sibutramine—obesity	0.000105	0.000636	CcSEcCtD
Rifaximin—Cough—Topiramate—obesity	0.000105	0.000636	CcSEcCtD
Rifaximin—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—obesity	0.000104	0.00231	CbGpPWpGaD
Rifaximin—Myalgia—Topiramate—obesity	0.000102	0.000621	CcSEcCtD
Rifaximin—Arthralgia—Topiramate—obesity	0.000102	0.000621	CcSEcCtD
Rifaximin—Chest pain—Topiramate—obesity	0.000102	0.000621	CcSEcCtD
Rifaximin—Dizziness—Bupropion—obesity	0.000102	0.000618	CcSEcCtD
Rifaximin—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.000101	0.000617	CcSEcCtD
Rifaximin—Discomfort—Topiramate—obesity	0.000101	0.000613	CcSEcCtD
Rifaximin—Dry mouth—Topiramate—obesity	9.99e-05	0.000607	CcSEcCtD
Rifaximin—Confusional state—Topiramate—obesity	9.88e-05	0.0006	CcSEcCtD
Rifaximin—Vomiting—Bupropion—obesity	9.78e-05	0.000594	CcSEcCtD
Rifaximin—Infection—Topiramate—obesity	9.73e-05	0.000591	CcSEcCtD
Rifaximin—Rash—Bupropion—obesity	9.69e-05	0.000589	CcSEcCtD
Rifaximin—Dermatitis—Bupropion—obesity	9.68e-05	0.000588	CcSEcCtD
Rifaximin—Shock—Topiramate—obesity	9.64e-05	0.000585	CcSEcCtD
Rifaximin—Headache—Bupropion—obesity	9.63e-05	0.000585	CcSEcCtD
Rifaximin—Nervous system disorder—Topiramate—obesity	9.61e-05	0.000584	CcSEcCtD
Rifaximin—Skin disorder—Topiramate—obesity	9.51e-05	0.000578	CcSEcCtD
Rifaximin—CYP3A4—Tryptophan metabolism—CYP2E1—obesity	9.48e-05	0.00211	CbGpPWpGaD
Rifaximin—Hyperhidrosis—Topiramate—obesity	9.47e-05	0.000575	CcSEcCtD
Rifaximin—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—obesity	9.36e-05	0.00209	CbGpPWpGaD
Rifaximin—Anorexia—Topiramate—obesity	9.34e-05	0.000567	CcSEcCtD
Rifaximin—Hypotension—Topiramate—obesity	9.15e-05	0.000556	CcSEcCtD
Rifaximin—NR1I2—Generic Transcription Pathway—NR3C1—obesity	9.14e-05	0.00204	CbGpPWpGaD
Rifaximin—Nausea—Bupropion—obesity	9.13e-05	0.000555	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Topiramate—obesity	8.92e-05	0.000542	CcSEcCtD
Rifaximin—Insomnia—Topiramate—obesity	8.86e-05	0.000538	CcSEcCtD
Rifaximin—Dyspnoea—Topiramate—obesity	8.73e-05	0.000531	CcSEcCtD
Rifaximin—NR1I2—Generic Transcription Pathway—PPARA—obesity	8.56e-05	0.00191	CbGpPWpGaD
Rifaximin—Decreased appetite—Topiramate—obesity	8.51e-05	0.000517	CcSEcCtD
Rifaximin—Gastrointestinal disorder—Topiramate—obesity	8.46e-05	0.000514	CcSEcCtD
Rifaximin—CYP3A4—Tryptophan metabolism—CYP19A1—obesity	8.45e-05	0.00188	CbGpPWpGaD
Rifaximin—Fatigue—Topiramate—obesity	8.44e-05	0.000513	CcSEcCtD
Rifaximin—Constipation—Topiramate—obesity	8.38e-05	0.000509	CcSEcCtD
Rifaximin—Pain—Topiramate—obesity	8.38e-05	0.000509	CcSEcCtD
Rifaximin—Feeling abnormal—Topiramate—obesity	8.07e-05	0.00049	CcSEcCtD
Rifaximin—Gastrointestinal pain—Topiramate—obesity	8.01e-05	0.000487	CcSEcCtD
Rifaximin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—obesity	7.93e-05	0.00177	CbGpPWpGaD
Rifaximin—Urticaria—Topiramate—obesity	7.78e-05	0.000473	CcSEcCtD
Rifaximin—NR1I2—Generic Transcription Pathway—ESR1—obesity	7.76e-05	0.00173	CbGpPWpGaD
Rifaximin—Abdominal pain—Topiramate—obesity	7.74e-05	0.00047	CcSEcCtD
Rifaximin—Body temperature increased—Topiramate—obesity	7.74e-05	0.00047	CcSEcCtD
Rifaximin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—obesity	7.66e-05	0.00171	CbGpPWpGaD
Rifaximin—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—obesity	7.56e-05	0.00169	CbGpPWpGaD
Rifaximin—Hypersensitivity—Topiramate—obesity	7.22e-05	0.000438	CcSEcCtD
Rifaximin—NR1I2—Generic Transcription Pathway—PPARG—obesity	7.08e-05	0.00158	CbGpPWpGaD
Rifaximin—Asthenia—Topiramate—obesity	7.03e-05	0.000427	CcSEcCtD
Rifaximin—CYP3A4—Cytochrome P450 - arranged by substrate type—NCOA1—obesity	6.93e-05	0.00155	CbGpPWpGaD
Rifaximin—Pruritus—Topiramate—obesity	6.93e-05	0.000421	CcSEcCtD
Rifaximin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—obesity	6.83e-05	0.00152	CbGpPWpGaD
Rifaximin—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—obesity	6.74e-05	0.0015	CbGpPWpGaD
Rifaximin—Diarrhoea—Topiramate—obesity	6.7e-05	0.000407	CcSEcCtD
Rifaximin—CYP3A4—Biological oxidations—CYP26B1—obesity	6.68e-05	0.00149	CbGpPWpGaD
Rifaximin—CYP3A4—Metapathway biotransformation—CYP26B1—obesity	6.59e-05	0.00147	CbGpPWpGaD
Rifaximin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—obesity	6.56e-05	0.00146	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—PARP1—obesity	6.5e-05	0.00145	CbGpPWpGaD
Rifaximin—Dizziness—Topiramate—obesity	6.48e-05	0.000394	CcSEcCtD
Rifaximin—NR1I2—Generic Transcription Pathway—SERPINE1—obesity	6.38e-05	0.00142	CbGpPWpGaD
Rifaximin—Vomiting—Topiramate—obesity	6.23e-05	0.000378	CcSEcCtD
Rifaximin—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—obesity	6.21e-05	0.00139	CbGpPWpGaD
Rifaximin—Rash—Topiramate—obesity	6.18e-05	0.000375	CcSEcCtD
Rifaximin—Dermatitis—Topiramate—obesity	6.17e-05	0.000375	CcSEcCtD
Rifaximin—NR1I2—Gene Expression—ESR2—obesity	6.16e-05	0.00137	CbGpPWpGaD
Rifaximin—Headache—Topiramate—obesity	6.14e-05	0.000373	CcSEcCtD
Rifaximin—CYP3A4—Biological oxidations—ADH1B—obesity	5.86e-05	0.00131	CbGpPWpGaD
Rifaximin—Nausea—Topiramate—obesity	5.82e-05	0.000353	CcSEcCtD
Rifaximin—NR1I2—Gene Expression—NCOA1—obesity	5.67e-05	0.00127	CbGpPWpGaD
Rifaximin—CYP3A4—Phase 1 - Functionalization of compounds—NCOA1—obesity	5.62e-05	0.00125	CbGpPWpGaD
Rifaximin—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—obesity	5.54e-05	0.00123	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—AR—obesity	5.44e-05	0.00121	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—SIRT1—obesity	4.96e-05	0.00111	CbGpPWpGaD
Rifaximin—CYP3A4—Biological oxidations—SULT2A1—obesity	4.51e-05	0.00101	CbGpPWpGaD
Rifaximin—CYP3A4—Metapathway biotransformation—SULT2A1—obesity	4.45e-05	0.000993	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—NR3C1—obesity	4.4e-05	0.000981	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—PRKCD—obesity	4.3e-05	0.000959	CbGpPWpGaD
Rifaximin—CYP3A4—Metapathway biotransformation—GPX3—obesity	4.25e-05	0.000947	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—PPARA—obesity	4.12e-05	0.00092	CbGpPWpGaD
Rifaximin—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—obesity	4.11e-05	0.000915	CbGpPWpGaD
Rifaximin—NR1I2—Generic Transcription Pathway—MYC—obesity	4.04e-05	0.0009	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—ESR1—obesity	3.74e-05	0.000833	CbGpPWpGaD
Rifaximin—CYP3A4—Metapathway biotransformation—AKR1C3—obesity	3.72e-05	0.00083	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—PPARG—obesity	3.41e-05	0.00076	CbGpPWpGaD
Rifaximin—CYP3A4—Phase 1 - Functionalization of compounds—POMC—obesity	3.33e-05	0.000742	CbGpPWpGaD
Rifaximin—CYP3A4—Biological oxidations—CYP2E1—obesity	3.3e-05	0.000736	CbGpPWpGaD
Rifaximin—CYP3A4—Metapathway biotransformation—CYP2E1—obesity	3.25e-05	0.000726	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—SERPINE1—obesity	3.07e-05	0.000685	CbGpPWpGaD
Rifaximin—CYP3A4—Biological oxidations—GGT1—obesity	3.03e-05	0.000676	CbGpPWpGaD
Rifaximin—CYP3A4—Biological oxidations—NCOA1—obesity	2.98e-05	0.000666	CbGpPWpGaD
Rifaximin—CYP3A4—Biological oxidations—CYP19A1—obesity	2.94e-05	0.000656	CbGpPWpGaD
Rifaximin—CYP3A4—Metapathway biotransformation—CYP19A1—obesity	2.9e-05	0.000647	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CA3—obesity	2.75e-05	0.000614	CbGpPWpGaD
Rifaximin—CYP3A4—Biological oxidations—COMT—obesity	2.73e-05	0.00061	CbGpPWpGaD
Rifaximin—CYP3A4—Metapathway biotransformation—COMT—obesity	2.7e-05	0.000601	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—GLRX—obesity	2.34e-05	0.000522	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—INSIG2—obesity	2.09e-05	0.000465	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PPM1L—obesity	2.09e-05	0.000465	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—OTC—obesity	2.09e-05	0.000465	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ETFDH—obesity	2.09e-05	0.000465	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—MYC—obesity	1.94e-05	0.000433	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—UQCRC2—obesity	1.91e-05	0.000425	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—INPP5E—obesity	1.91e-05	0.000425	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—GPT—obesity	1.91e-05	0.000425	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ME1—obesity	1.77e-05	0.000395	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ALDH6A1—obesity	1.77e-05	0.000395	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—SUCLG2—obesity	1.77e-05	0.000395	CbGpPWpGaD
Rifaximin—CYP3A4—Biological oxidations—POMC—obesity	1.77e-05	0.000394	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—UCP1—obesity	1.67e-05	0.000372	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—COX7C—obesity	1.67e-05	0.000372	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PNPLA3—obesity	1.67e-05	0.000372	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CS—obesity	1.58e-05	0.000352	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—DGAT2—obesity	1.58e-05	0.000352	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—SUCLA2—obesity	1.58e-05	0.000352	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CPS1—obesity	1.58e-05	0.000352	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—LIPE—obesity	1.51e-05	0.000336	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—MUT—obesity	1.51e-05	0.000336	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—DGAT1—obesity	1.45e-05	0.000322	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CYB5A—obesity	1.45e-05	0.000322	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ACLY—obesity	1.39e-05	0.00031	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—AKT1—obesity	1.35e-05	0.0003	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ALOX12—obesity	1.34e-05	0.0003	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ENPP1—obesity	1.34e-05	0.0003	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—HMGCS1—obesity	1.3e-05	0.00029	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PLIN1—obesity	1.26e-05	0.000282	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ACADM—obesity	1.26e-05	0.000282	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—SAT1—obesity	1.26e-05	0.000282	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PNPLA2—obesity	1.26e-05	0.000282	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PFKFB3—obesity	1.26e-05	0.000282	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ANGPTL4—obesity	1.26e-05	0.000282	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ACACB—obesity	1.23e-05	0.000274	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—OXCT1—obesity	1.23e-05	0.000274	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CYTB—obesity	1.23e-05	0.000274	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—SRD5A1—obesity	1.2e-05	0.000267	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PNLIP—obesity	1.2e-05	0.000267	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—SDC3—obesity	1.17e-05	0.000261	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CYP26B1—obesity	1.14e-05	0.000255	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—HK2—obesity	1.14e-05	0.000255	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—STS—obesity	1.14e-05	0.000255	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PPARD—obesity	1.12e-05	0.000249	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—SLC27A1—obesity	1.1e-05	0.000244	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—GLUL—obesity	1.07e-05	0.00024	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—FABP4—obesity	1.07e-05	0.00024	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—UCP2—obesity	1.02e-05	0.000227	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ECHS1—obesity	1.02e-05	0.000227	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—HSD11B1—obesity	1.02e-05	0.000227	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—UCP3—obesity	1.02e-05	0.000227	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ADH1B—obesity	1e-05	0.000223	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—GPAM—obesity	9.86e-06	0.00022	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PPARGC1B—obesity	9.86e-06	0.00022	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ACSL1—obesity	9.86e-06	0.00022	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—HADH—obesity	9.58e-06	0.000214	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—FADS1—obesity	9.58e-06	0.000214	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PCK1—obesity	9.58e-06	0.000214	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ACP5—obesity	9.32e-06	0.000208	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—G6PD—obesity	9.08e-06	0.000202	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—HK1—obesity	8.97e-06	0.0002	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—SREBF2—obesity	8.97e-06	0.0002	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—LPA—obesity	8.66e-06	0.000193	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—LPIN1—obesity	8.47e-06	0.000189	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—APOA5—obesity	8.3e-06	0.000185	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CLOCK—obesity	7.92e-06	0.000177	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—SLC22A1—obesity	7.92e-06	0.000177	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—SULT2A1—obesity	7.72e-06	0.000172	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—GLP1R—obesity	7.72e-06	0.000172	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—DPYD—obesity	7.59e-06	0.000169	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PRKAR2B—obesity	7.31e-06	0.000163	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—DCN—obesity	7.26e-06	0.000162	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CPT1A—obesity	7.06e-06	0.000157	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—NAMPT—obesity	6.92e-06	0.000154	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—LIPC—obesity	6.88e-06	0.000153	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—GCK—obesity	6.88e-06	0.000153	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—APOC3—obesity	6.84e-06	0.000152	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CETP—obesity	6.64e-06	0.000148	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—SDC1—obesity	6.56e-06	0.000146	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—AKR1C3—obesity	6.46e-06	0.000144	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—SCARB1—obesity	6.36e-06	0.000142	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—SREBF1—obesity	6.17e-06	0.000138	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—GOT2—obesity	6e-06	0.000134	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—FASN—obesity	5.87e-06	0.000131	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—BCHE—obesity	5.85e-06	0.00013	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CYP2E1—obesity	5.64e-06	0.000126	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—NQO1—obesity	5.58e-06	0.000124	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—SLC2A4—obesity	5.35e-06	0.000119	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—GCG—obesity	5.35e-06	0.000119	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CYCS—obesity	5.28e-06	0.000118	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—GGT1—obesity	5.18e-06	0.000116	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—GOT1—obesity	5.18e-06	0.000116	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—NCOA1—obesity	5.1e-06	0.000114	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—STK11—obesity	5.03e-06	0.000112	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CYP19A1—obesity	5.03e-06	0.000112	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—COMT—obesity	4.68e-06	0.000104	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—GNB3—obesity	4.61e-06	0.000103	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PPARGC1A—obesity	4.61e-06	0.000103	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—HMOX1—obesity	4.59e-06	0.000102	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—GNAS—obesity	4.49e-06	0.0001	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—APOB—obesity	4.4e-06	9.81e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—LPL—obesity	4.2e-06	9.36e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—GPX1—obesity	4.1e-06	9.13e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CD36—obesity	3.99e-06	8.9e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—MTHFR—obesity	3.78e-06	8.43e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PPARA—obesity	3.71e-06	8.27e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—AGT—obesity	3.59e-06	8.01e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—APOE—obesity	3.52e-06	7.85e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CAV1—obesity	3.49e-06	7.78e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—APOA1—obesity	3.48e-06	7.76e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PIK3CG—obesity	3.18e-06	7.08e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PPARG—obesity	3.07e-06	6.84e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—POMC—obesity	3.02e-06	6.74e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—INS—obesity	3.01e-06	6.7e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PIK3CD—obesity	2.79e-06	6.23e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ALB—obesity	2.76e-06	6.15e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—NOS3—obesity	2.64e-06	5.88e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PIK3R1—obesity	2.64e-06	5.88e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PIK3CB—obesity	2.43e-06	5.43e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PTGS2—obesity	2.41e-06	5.38e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PIK3CA—obesity	1.48e-06	3.31e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—AKT1—obesity	1.21e-06	2.7e-05	CbGpPWpGaD
